# OR52L1

## Overview
The OR52L1 gene encodes the protein olfactory receptor family 52 subfamily L member 1, which is a member of the G protein-coupled receptor (GPCR) superfamily. These receptors are characterized by their seven-transmembrane domain structure, which is essential for their role in detecting odorant molecules and initiating signal transduction pathways. OR52L1 is primarily expressed in the olfactory epithelium, where it contributes to the sense of smell by recognizing and binding specific odorants. Beyond its role in olfaction, OR52L1 is also expressed in non-olfactory tissues, including the brain, where it may participate in developmental processes such as axon guidance. Alterations in the expression of OR52L1 have been associated with neurodegenerative diseases like Parkinson's disease and psychiatric conditions such as schizophrenia, highlighting its potential significance in these disorders (Lin2021Identification; Ansoleaga2015Decrease; GarciaEsparcia2013Functional).

## Structure
OR52L1 is a member of the olfactory receptor family, which are G protein-coupled receptors (GPCRs) characterized by a seven-transmembrane domain structure. This structure is typical of GPCRs, allowing them to interact with odorant molecules and initiate signal transduction (Lin2021Identification; Jimenez2021The). The primary structure of OR52L1 consists of amino acid sequences that form the protein, while the secondary structure includes alpha helices that span the cell membrane (Jimenez2021The). The tertiary structure involves the folding of these helices into a three-dimensional shape, which is crucial for the receptor's function in recognizing and binding odorant molecules (Lin2021Identification).

Post-translational modifications such as glycosylation and phosphorylation may occur, potentially affecting the receptor's function and localization, although specific modifications for OR52L1 are not detailed in the provided context (Jimenez2021The). The OR52L1 gene has been associated with a missense variant, rs762369133, which results in a His106Pro substitution, potentially impacting the protein's conformation and function due to the alteration of a highly conserved histidine residue to proline (Lin2021Identification). There is no information provided on quaternary structure or splice variant isoforms for OR52L1.

## Function
The OR52L1 gene encodes a protein that is part of the olfactory receptor family, specifically involved in the detection of odorant molecules. These receptors are G-protein-coupled receptors (GPCRs) characterized by a seven-transmembrane domain structure, which is shared with many neurotransmitter and hormone receptors. OR52L1 plays a crucial role in the recognition and G-protein-mediated transduction of odorant signals, initiating a neuronal response that leads to the perception of smell (Lin2021Identification).

OR52L1 is primarily active in the olfactory epithelium, where it interacts with specific odorant molecules to trigger signaling pathways that result in the sense of smell (Lin2021Identification). The gene is also involved in broader physiological processes beyond olfaction, as it is expressed in non-olfactory tissues such as the brain. In the brain, OR52L1 is expressed in the frontal cortex and is involved in developmental processes like axon guidance and target recognition (Oh1970SystemWide). The expression of OR52L1 in the brain is downregulated in neurodegenerative diseases such as Parkinson's disease, suggesting a potential role in these conditions (GarciaEsparcia2013Functional).

## Clinical Significance
The gene OR52L1 has been implicated in several neurological and sensory conditions due to its altered expression levels. In Parkinson's disease (PD), OR52L1 is significantly downregulated in the frontal cortex, particularly in area 8, which may contribute to the olfactory dysfunction commonly observed in PD patients. This downregulation is noted in both premotor and parkinsonian stages, suggesting a potential role in the early sensory perception deficits associated with the disease (GarciaEsparcia2013Functional).

In chronic schizophrenia, OR52L1 expression is also significantly decreased in the dorsolateral prefrontal cortex. This downregulation is associated with the pathophysiology of schizophrenia and may be influenced by antipsychotic treatment, although the exact mechanisms remain unclear (Ansoleaga2015Decrease).

Additionally, a missense variant in OR52L1 has been identified in retinitis pigmentosa (RP) patients. Although this variant is predicted to be benign, its presence in affected individuals suggests a potential, albeit unclear, role in the disease's pathogenesis (Lin2021Identification). The clinical significance of OR52L1 mutations in RP remains to be fully understood, as it is a novel finding in this context (Lin2021Identification).


## References


[1. (Oh1970SystemWide) S. June Oh. System-wide expression and function of olfactory receptors in mammals. Genomics &amp; Informatics, 16(1):2–9, January 1970. URL: http://dx.doi.org/10.5808/gi.2018.16.1.2, doi:10.5808/gi.2018.16.1.2. This article has 16 citations.](https://doi.org/10.5808/gi.2018.16.1.2)

[2. (Ansoleaga2015Decrease) Belén Ansoleaga, Paula Garcia-Esparcia, Raquel Pinacho, Josep Maria Haro, Belén Ramos, and Isidre Ferrer. Decrease in olfactory and taste receptor expression in the dorsolateral prefrontal cortex in chronic schizophrenia. Journal of Psychiatric Research, 60:109–116, January 2015. URL: http://dx.doi.org/10.1016/j.jpsychires.2014.09.012, doi:10.1016/j.jpsychires.2014.09.012. This article has 54 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jpsychires.2014.09.012)

[3. (Jimenez2021The) Ramón Cierco Jimenez, Nil Casajuana-Martin, Adrián García-Recio, Lidia Alcántara, Leonardo Pardo, Mercedes Campillo, and Angel Gonzalez. The mutational landscape of human olfactory g protein-coupled receptors. BMC Biology, February 2021. URL: http://dx.doi.org/10.1186/s12915-021-00962-0, doi:10.1186/s12915-021-00962-0. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s12915-021-00962-0)

[4. (Lin2021Identification) Ting-Yi Lin, Yun-Chia Chang, Yu-Jer Hsiao, Yueh Chien, Ying-Chun Jheng, Jing-Rong Wu, Lo-Jei Ching, De-Kuang Hwang, Chih-Chien Hsu, Tai-Chi Lin, Yu-Bai Chou, Yi-Ming Huang, Shih-Jen Chen, Yi-Ping Yang, and Ping-Hsing Tsai. Identification of novel genomic-variant patterns of or56a5, or52l1, and ctsd in retinitis pigmentosa patients by whole-exome sequencing. International Journal of Molecular Sciences, 22(11):5594, May 2021. URL: http://dx.doi.org/10.3390/ijms22115594, doi:10.3390/ijms22115594. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms22115594)

[5. (GarciaEsparcia2013Functional) Paula Garcia-Esparcia, Agatha Schlüter, Margarita Carmona, Jesús Moreno, Belen Ansoleaga, Benjamín Torrejón-Escribano, Stefano Gustincich, Aurora Pujol, and Isidre Ferrer. Functional genomics reveals dysregulation of cortical olfactory receptors in parkinson disease: novel putative chemoreceptors in the human brain. Journal of Neuropathology &amp; Experimental Neurology, 72(6):524–539, June 2013. URL: http://dx.doi.org/10.1097/NEN.0b013e318294fd76, doi:10.1097/nen.0b013e318294fd76. This article has 135 citations.](https://doi.org/10.1097/NEN.0b013e318294fd76)